Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis

Table 3 Subgroup and Meta-regression analysis of VAI in the diagnosis of MAFLD in included studies

Subgroup	Number of studies	Sen(95%CI)	Spe(95%CI)	PLR(95%CI)	NLP(95%CI)	DOR(95%CI)	RDOR(95%CI)	P
Diagnostic methods
Biopsy	2[11, 18]	0.79(0.74–0.83)	0.84(0.76–0.89)	5.00(1.27–19.72)	0.24(0.19–0.30)	19.79(4.8-81.63)	4.06(1.87–8.79)	0.0036
Imaging examination	7[10, 12,13,14,15,16,17]	0.70(0.69–0.70)	0.67(0.67–0.68)	1.99(1.80–2.19)	0.43(0.39–0.47)	4.96(4.26–5.79)	4.06(1.87–8.79)	0.0036
Control source
Healthy	2[10, 18]	0.78(0.68–0.85)	0.72(0.64–0.79)	2.75(2.06–3.67)	0.31(0.21–0.46)	8.78(4.76–16.06)	1.38(0.35–5.40)	0.5898
Non-MAFLD	7[11,12,13,14,15,16,17]	0.70(0.69–0.70)	0.67(0.67–0.68)	2.01(1.80–2.25)	0.39(0.35–0.45)	5.55(4.48–6.88)	1.38(0.35–5.40)	0.5898
Race
Asian	3[12, 16, 17]	0.70(0.69–0.70)	0.67(0.67–0.68)	2.04(1.86–2.24)	0.43(0.39–0.48)	4.84(4.07–5.75)	1.70(0.69–4.22)	0.2091
European	6[10, 11, 13,14,15, 18]	0.76(0.72–0.79)	0.67(0.64–0.71)	2.66(1.61–4.38)	0.33(0.24–0.45)	8.39(4.38–16.05)	1.70(0.69–4.22)	0.2091

Abbreviations: Sen Sensitivity Spe Specificity, PLR Positive likelihood ratio, NLR Negative likelihood ratio, DOR Diagnostic odds ratio, RDOR Relative diagnostic odds ratio, MAFLD metabolic-associated fatty liver disease
The P value represents the statistical difference of DOR between different groups

ISSN: 1476-511X